Category Innovation/ R&D

New Thinking On Biotech Patents From Industry Groups

LYON, FRANCE - A new level of willingness to cooperate on major public health initiatives may indicate increased convergence in goals between large pharmaceutical companies and patient advocacy groups, particularly when addressing neglected diseases, a panel at an international life sciences conference said Monday.

WHO Launches Online Hearing On Innovative Funding Sources For R&D

The World Health Organization is soliciting new ideas for funding sources to stimulate research and development on diseases predominantly afflicting developing countries, with some in developed countries. The web-based public hearing, being held online from 7 March to 15 April, will contribute to an intergovernmental mandate to come up with ways to address the shortage of research in this areas.

US Patent Reform Bills And Jobs: Critical Timing, Critical Differences

The United States patent reform bills offered up Tuesday fall well short of what is needed to protect innovation and intellectual property rights, say myriad small tech companies, large-cap manufacturers, pharmaceutical firms and inventors. In fact, they say, it even threatens jobs at a time when the economy is in desperate need of them.

But proponents argue that it is precisely the type of measure needed to promote jobs, reduce lawsuits and poor patent quality that put a drag on innovation and the economy.

In Biotech Industry, Cash Flow Fears And Patent Questions

Patent reform, universal health care, and intellectual property rights protection of new health and environmental technologies are critical not only for the biotechnology industry but for improvements in public health, the president of the Biotechnology Industry Organization (BIO) said Thursday.

Innovation Policy: The Balance Between Standards and Patent Regulation

greveBy Georg Greve

Interconnectivity, commoditisation and increased reuse and recombination are key trends within the maturing information and communication technologies (ICT) industry that drive innovation and development. Harnessing the innovative and economic potential of the ICT sector depends on a variety of factors, including open innovation models, such as free software.

Enforcement, Creative R&D Financing Priority Issues For Public Health in 2009

The number and intensity of debates over the role of intellectual property rights in public health is set to increase in 2009.

New leadership and new mandates for key intergovernmental organisations implemented last year have created opportunity for change. And while old debates over the balance between IP rights and access to health products are not going away, this year will see more exploration at the intergovernmental level of different systems to stimulate innovation.

Proponents Explore Designs For Prizes To Aid Neglected Disease Research

The World Health Organization global strategy on public health, innovation and intellectual property calls for the exploration of alternative mechanisms to incentivise research and development, including the use of prize funds. A diverse group of non-governmental agencies, government and pharmaceutical industry representatives recently looked at prize funds in detail, to determine different possible approaches and where they might best be applied to medical innovations.